The placebo response in medicine: minimize, maximize or personalize?
The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Abstract
Our understanding of the mechanisms mediating or moderating the placebo response to medicines has grown substantially over the past decade and offers the opportunity to capitalize on its benefits in future drug development as well as in clinical practice. In this article, we discuss three strategies that could be used to modulate the placebo response, depending on which stage of the drug development process they are applied. In clinical trials the placebo effect should be minimized to optimize drug-placebo differences, thus ensuring that the efficacy of the investigational drug can be truly evaluated. Once the drug is approved and in clinical use, placebo effects should be maximized by harnessing patients' expectations and learning mechanisms to improve treatment outcomes. Finally, personalizing placebo responses - which involves considering an individual's genetic predisposition, personality, past medical history and treatment experience - could also maximize therapeutic outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This might be due to patients' expectations of benefits in clinical trials with novel substances, behavioral conditioning in research settings, or the striking overlap in neuroanatomical substrates between affected brain regions in MDD and placebo response [161]”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [161]
Citations
Cites
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
Moseley, J. B., O'Malley, K., Petersen, N. J., Menke, T. J., Brody, B. A., Kuykendall, D. H., Hollingsworth, J. C., Ashton, C. M., & Wray, N. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013259 · Cited by 2,149
Biological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., et al. (2008) · BMJ · doi:10.1136/bmj.39524.439618.25 · Cited by 1,196
THE MECHANISM OF PLACEBO ANALGESIA
Levine, J., Gordon, N., & Fields, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92762-9 · Cited by 1,094
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
Jackevicius, C. A. (2002) · JAMA · doi:10.1001/jama.288.4.462 · Cited by 1,077
A New Design for Randomized Clinical Trials
Zelen, M. (1979) · New England Journal of Medicine · doi:10.1056/nejm197905313002203 · Cited by 1,055
Behaviorally Conditioned Immunosuppression
Ader, R., & Cohen, N. (1975) · Psychosomatic Medicine · doi:10.1097/00006842-197507000-00007 · Cited by 1,018
Research works printed but not linked: 1
- Kaptchuk, T. J. et al. Do “placebo responders” exist? Contemp. Clin. Trials. 29, 587–595 (2008). · DOI
Cited by
Items 401–500 of 674
Is Placebo Response Responsible for Many Phase III Failures?
Dumitrescu, T. P., McCune, J., & Schmith, V. D. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1632 · Cited by 8
“, patient’s expectations of benefit of treatment), behavioral conditioning, and the number and quality of patient– physician relationship(s).(10) Indeed, once efficacy is achieved in phase II, both physician and patient expectancy increases, which can elevate the likelihood of a placebo response in phase III.”
BackgroundNegative expectations (nocebo phenomenon) in clinical interventions: A scoping review
Nasiri‐Dehsorkhi, H., Vaziri, S., Esmaillzadeh, A., & Adibi, P. (2024) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_269_23 · Cited by 6
“[68,69] The fourth method is different from the previous three methods.”
MethodLunde, S. J., Vase, L., Hall, K. T., Meißner, K., Hohenschurz‐Schmidt, D., Kaptchuk, T. J., Maier, C., & Vollert, J. (2025) · Pain · doi:10.1097/j.pain.0000000000003615 · Cited by 8
Benson, S., Theysohn, N., Kleine‐Borgmann, J., Rebernik, L., Icenhour, A., & Elsenbruch, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.824468 · Cited by 8
“Enhancing awareness of and knowledge about expectancy effects and their determinants in the context of the gut-brain axis hence holds much promise to further improve the care of the large group of patients with disturbed gut-brain interactions, like IBS, consistent with the vision to maximize positive and minimize neg…”
BackgroundFunctional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease
Barbero, J., Unadkat, P., Choi, Y. Y., & Eidelberg, D. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01433-w · Cited by 8
“The psychobio-logical mechanism underlying the placebo response in PD is not fully understood [125–129].”
BackgroundSchwarting, R. K. W., Wöhr, M., Engler, H., Sungur, A. Ö., & Schedlowski, M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105721 · Cited by 8
“Yet, clinical analyses of drug treatments rarely consider associative learning, which could optimize patient treatment and enhance trial sensitivity by highlighting drug-placebo differences (Enck et al., 2013).”
BackgroundSelf-citationFactors associated with a placebo effect in Parkinson’s disease in clinical trials: a meta-analysis
Haji, S., Sako, W., Murakami, N., Osaki, Y., & Izumi, Y. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12529-4 · Cited by 9
“Such a run-in phase was originally expected to attenuate the placebo effect [24], but questions have recently been raised concerning placebo suppression by a placebo run-in phase in other diseases [15].”
Weimer, K., Horing, B., Muth, E. R., Scisco, J. L., Klosterhalfen, S., & Enck, P. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.11.022 · Cited by 7
Self-citationPlasma cortisol response cannot be classically conditioned in a taste-endocrine paradigm in humans
Petrakova, L., Boy, K., Kügler, M., Benson, S., Engler, H., Möller, L. C., & Schedlowski, M. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4718-2 · Cited by 7
Self-citationWorth a try – A survey on the general acceptance of open-label placebos
Forkmann, K., Müßgens, D., Hashim, A., & Bingel, U. (2022) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2022.111096 · Cited by 7
Self-citationGoo, S. J., Frangos, E., Richards, E. A., Čeko, M., Justement, B. L., Korb, P., Walitt, B. T., Colloca, L., & Bushnell, M. C. (2019) · Pain Medicine · doi:10.1093/pm/pnz081 · Cited by 8
Hölsken, S., Krefting, F., Schedlowski, M., & Sondermann, W. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047099 · Cited by 7
Self-citationMaximizing placebo response in neurological clinical practice
Mariani, L., & Corvol, J. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.04.003 · Cited by 9
Horn, N., Gärtner, L., Rastan, A. J., Andrási, T. B., Lenz, J., Böning, A., Salzmann-Djufri, M., Puvogel, U., Niemann, B., Genovese, M., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.01.006 · Cited by 9
Self-citationWessels, J., Klinger, R., Benson, S., Brenner, T., Elsenbruch, S., & Aulenkamp, J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1396562 · Cited by 6
“…recognized as underlying expectancy effects: Verbal information or instruction provided by healthcare professionals (cognitive model), classical conditioning (associative learning) and social learning (observational learning) (16), which generate the expectation-mediated placebo effect (34).”
BackgroundTreatment expectations of patients and clinicians: a cross-sectional study
Li, J., Xiao, C., Li, T., Duan, Y., Jiang, Y., Shi, L., Hong, X., Geng, W., Hu, J., Wang, Y., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1447405 · Cited by 7
Mafla-España, M. A., & Cauli, O. (2025) · Diseases · doi:10.3390/diseases13030080 · Cited by 7
“These elements, supported by empirical evidence, play a key role in therapeutic outcomes [95–98].”
Watolla, D., Mazurak, N., Gruss, S., Gulewitsch, M. D., Schwille‐Kiuntke, J., Sauer, H., Enck, P., & Weimer, K. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00213 · Cited by 6
“To date many aspects concerning the placebo response and effect have been discovered, for example mechanisms, mediators and moderators (1, 3).”
BackgroundMethodSelf-citationSchmidt, K., Kleine‐Borgmann, J., Holle, D., Gaul, C., & Bingel, U. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045969 · Cited by 6
Self-citationZunhammer, M., Goltz, G., Schweifel, M., Stuck, B. A., & Bingel, U. (2022) · Clinical and Translational Science · doi:10.1111/cts.13397 · Cited by 7
Self-citationWolter, T., & Kleinmann, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206968 · Cited by 6
Placebo Manipulations Reverse Pain Potentiation by Unpleasant Affective Stimuli
Reicherts, P., Pauli, P., Camilla, M., & Wieser, M. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00663 · Cited by 8
“Significant modifications have been found for various somatic symptoms (12) and also for the perception of emotions.”
Placebo, nocebo: Believing in the field of medicine
Meißner, K. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.972169 · Cited by 8
“Placebo and nocebo effects can affect almost any medical symptom, including but not limited to pain, itch, nausea, depression, and motor symptoms (7).”
BackgroundEnck, P., Weimer, K., & Klosterhalfen, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397928-5.00016-7 · Cited by 6
Self-citationHasuo, H., Matsuoka, H., Matsuda, Y., & Fukunaga, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.592776 · Cited by 8
“Furthermore, it has been proposed that placebo effects should be used to a maximum extent to raise patients’ expectations and improve treatment outcomes (7).”
BackgroundHahn, S., Nestoriuc, Y., Kirchhof, S., Toussaint, A. C., Löwe, B., & Pauls, F. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-091032 · Cited by 8
“20 25 Since there is a lack of knowledge regarding the short-term influence of symptom-related expectations on somatic symptom severity, further investigation is warranted to clarify this relationship.”
Schmidt, J., Reinold, J., Rohn, H., Schedlowski, M., Engler, H., Elsenbruch, S., & Benson, S. (2025) · BMC Medicine · doi:10.1186/s12916-025-04292-8 · Cited by 6
“To this end, we implemented a fully balanced 2 × 2 factorial study design [4] (see Fig.”
InfluentialSelf-citationPlacebo Effects Are Small on Average in the 7.5% CO2 Inhalational Model of Generalized Anxiety
Huneke, N. T. M., Cross, C., Fagan, H. A., Molteni, L., Phillips, N., Garner, M. J., & Baldwin, D. S. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae019 · Cited by 5
“This can affect the ability of a clinical trial to distinguish efficacy of active treatment from placebo, hindering psychotropic drug development over time (Enck et al., 2013; Huneke et al., 2020a; Huneke, 2022; Correll et al., 2023).”
Learning how to make use of dissociative therapies
Mathai, D. S. (2024) · International Review of Psychiatry · doi:10.1080/09540261.2024.2406329 · Cited by 6
“Rather than attempting to isolate specific from nonspecific influences, clinicians and researchers may be better served by learning how to optimize and synergize them (Colloca & Barsky, 2020; Enck et al., 2013).”
Lopresti, A. L., Smith, S. J., Marx, W., Díez‐Municio, M., & Morán-Valero, M. I. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.05.024 · Cited by 7
Ethical Overview of Placebo Control in Psychiatric Research - Concepts and Challenges.
Ćurković, M., Živković, M., Radić, K., Vilibić, M., Ćelić, I., & Bagarić, D. (2015) · PubMed · Cited by 6
Placebo- und Noceboeffekte bei Pruritus: Methodologische und klinische Implikationen
Tekampe, J., Peerdeman, K. J., Bartels, D. J. P., van Laarhoven, A. I. M., & Evers, A. W. M. (2018) · Der Hautarzt · doi:10.1007/s00105-018-4211-9 · Cited by 6
Re-evaluation of Significance and the Implications of Placebo Effect in Antidepressant Therapy
Ćurković, M., Košec, A., & Savić, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00143 · Cited by 6
“It is responsible for physical changes and effects in individuals that are specific and somewhat related to the investigated condition and/or effects of “true” treatment (1, 2, 16, 19, 20).”
BackgroundInfluentialThe Effect of Expectations on Experiences and Engagement with an Applied Game for Mental Health
Wols, A., Hollenstein, T., Lichtwarck‐Aschoff, A., & Granic, I. (2021) · Games for Health Journal · doi:10.1089/g4h.2020.0115 · Cited by 8
Maß, R., Backhaus, K., Szelies, M., & Unkelbach, B. K. (2023) · Verhaltenstherapie · doi:10.1159/000528902 · Cited by 5
“…Wirkung der Medikamente von allen anderen möglichen Einflüssen unterschieden werden; dazu gehören der Placebo-Effekt (Erwartungen, Lernprozesse, Beziehung zwischen Ärzt*innen und Patient*innen [vgl. Enck et al., 2013]), aber u.a. auch der natürliche Krankheitsverlauf oder Regressionseffekte.”
BackgroundMediators of Placebo Response to Cannabinoid Treatment in Children with Autism Spectrum Disorder
Aran, A. A., Harel, M., Ovadia, A., Shalgy, S., & Cayam-Rand, D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093098 · Cited by 6
“The most established factors underlying the placebo effect are treatment expectation, behavioral conditioning, and the quality of the patient–physician relationship [7,8].”
BackgroundDie dunkle Seite der Intervention - was hat Placebo mit Psychotherapie zu tun?
Rief, W., & Gaab, J. (2016) · Verhaltenstherapie · doi:10.1159/000443975 · Cited by 5
“…wie z.B. die klinisch bedeutsamen Effekte von Erwartungen, behandlungsbezogenen Vorerfahrungen sowie bewussten als auch unbewussten interpersonalen Behandlungsmerkmalen nicht nur von großer Relevanz für medizinische [Enck et al., 2013], sondern auch für psychotherapeutische Interventionen.”
BackgroundSelf-citationLee, G. J., & Suhr, J. A. (2018) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acy026 · Cited by 8
Web-based exercise therapy for the treatment of depression: Perspectives from sports science
Haller, N. (2022) · Sports Psychiatry · doi:10.1024/2674-0052/a000016 · Cited by 5
Winkler, A., Rheker, J., Doering, B. K., & Rief, W. (2016) · Psychophysiology · doi:10.1111/psyp.12695 · Cited by 6
Self-citationSharma, T., Ma, C., Sedaño, R., Hanžel, J., McDonald, C. L., Hogan, M., Kochhar, G. S., Narula, N., Peyrin‐Biroulet, L., Danese, S., et al. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac160 · Cited by 4
Salzmann, S., Stenzel, K. L., Sadlonova, M., Euteneuer, F., Horn, N., Rastan, A. J., Lenz, J., Böning, A., Salzmann-Djufri, M., Niemann, B., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-93467-7 · Cited by 5
Self-citationHuang, A., Zhang, A., Lee, D. J., & Ying, G. (2025) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2025.08.014 · Cited by 4
Winkler, A., Meis, A. C., & Hermann, C. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00366-9 · Cited by 6
“Placebo responses are largely driven by implicit and explicit expectations of treatment efficacy which can be acquired by associative learning such as classical conditioning or observational learning, are influenced by verbal information and contextual factors (Enck et al. 2013).”
Vermeijden, N. K., van der Feen, C., Groeneweg, M., Hummel, T., Zagers, D. A., Maartens, I. A. B., van Wering, H. M., Hurkmans, P., Stapelbroek, J. M., Sauvé, I., et al. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2026.01.014 · Cited by 4
Hartmann, H., Banwinkler, M., Riva, F., & Lamm, C. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1257522 · Cited by 5
“…has been discussed as a potential reason for the failure of many randomized placebo-controlled clinical trials – the gold standard for the confirmatory proof of efficacy of new pharmaceuticals - as it may hamper the demonstration of a drug’s efficacy (Enck et al., 2013; Stahl and Greenberg, 2019).”
BackgroundOpen-label placebos reduce weight in obesity: a randomized controlled trial
Schaefer, M., Kühnel, A., & Enge, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-69866-7 · Cited by 5
The Relevance of Placebo and Nocebo Mechanisms for Analgesic Treatments
Bingel, U. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397928-5.00013-1 · Cited by 4
Self-citationPersonalized nutrition: from science to consumer
Zhu, Y., Koecher, K. J., Benoit, V., Normington, J., Menon, R. S., & Campbell, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85615-7.00017-3 · Cited by 6
Kleine‐Borgmann, J., Wilhelmi, J., Kratel, J., Baumann, F., Schmidt, K., Zunhammer, M., & Bingel, U. (2021) · Clinical and Translational Science · doi:10.1111/cts.13058 · Cited by 5
Self-citationSympathetic Arousal during a Touch-Based Healing Ritual Predicts Increased Well-Being
Meißner, K., & Koch, A. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/641704 · Cited by 5
“Nonspecific effects (synonymous with placebo effects) are thought to be due to psychobiological processes triggered by the overall therapeutic context [2] and are mediated by the patient’s expectations towards the treatment, previous experience with treatments (learning), and characteristics of the patient-provider-in…”
BackgroundMarchand, S., & Gaumond, I. (2014) · Douleur et Analgésie · doi:10.1007/s11724-014-0403-y · Cited by 7
“liser l’efficacité d’un traitement [23].”
Effect of patients’ expectations on clinical response to fampridine treatment
Ladeira, F. F., Mendonça, M., Caetano, A., Salavisa, M., Delgado, H., Correia, A. S., & Baptista, M. V. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3613-x · Cited by 4
Longer-Term Therapy for Symptoms Attributed to Lyme Disease
Kullberg, B. J., Berende, A., & Evers, A. W. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1608044 · Cited by 4
Nocebo effects and psychotropic drug action - an update
Amanzio, M., & Palermo, S. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1722100 · Cited by 4
Rodrigues, A., Nader, S. A., Daniel, N. G., & Emami, E. (2025) · Clinical Oral Implants Research · doi:10.1111/clr.14432 · Cited by 3
“Additionally, expectations may motivate patients to adopt favorable health behaviors and coping strategies (Enck et al. 2013).”
Understanding specific, contextual and non-specific effects in osteopathy
Tripodi, N., Lawton, A., Corcoran, D., & Feehan, J. (2025) · International journal of osteopathic medicine · doi:10.1016/j.ijosm.2025.100773 · Cited by 3
Ribichini, E., SCOTTI, G. B., Cola, S. D., Scalese, G., Severi, C., & Vernia, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124351 · Cited by 3
“Enck 2013 [59] Longer Trial Duration * PE is reduced in long-duration trials.”
InfluentialCaliskan, E. B., Schmidt, K., Hellmann, A., Spisák, T., Bingel, U., & Kleine‐Borgmann, J. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1522634 · Cited by 3
Self-citationGerger, H., Buergler, S., Sezer, D., Grethler, M., Gaab, J., & Locher, C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00897 · Cited by 4
“When turning from the highly controlled setting of health outcome research towards the practice of healthcare, where the actual improvement of a presenting patients’ health is the major goal, several questions regarding the role of the non-specific treatment aspects and their potential effects arise: How relevant are…”
BackgroundPlacebos, caring, and healing in rheumatology
Dieppe, P. A., Marsden, D., & Goldingay, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00263-1 · Cited by 3
He, D., Jiang, B., Guo, Z., Mu, Q., & McClure, M. A. (2019) · SLEEP · doi:10.1093/sleep/zsz238 · Cited by 3
Faria, V., Han, P., Joshi, A., Enck, P., & Hummel, T. R. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.11.007 · Cited by 5
Self-citationHoring, B., Beadle, S. C., Inks, Z. J., Robb, A. C., Muth, E. R., & Babu, S. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-77453-9 · Cited by 4
Paschke, L. M., Dreyer, N., Worm, M., & Klinger, R. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-074957 · Cited by 3
“46 This study aims to influence the participants’ expectation via different forms of verbal information regarding the placebos.”
BackgroundPsychophysiologische Grundlagen viszeraler Schmerzen
Horing, B., & Enck, P. (2014) · Der Schmerz · doi:10.1007/s00482-014-1403-9 · Cited by 3
Self-citationUsing the Placebo Effect to Isolate Control Mechanisms of Athletic Performance: A Research Protocol
Broelz, E. K., Enck, P., Niess, A. M., Schneeweiß, P., & Weimer, K. (2015) · Sports and Exercise Medicine - Open Journal · doi:10.17140/semoj-1-109 · Cited by 3
Self-citationShackleton, E., Toutt, C., & Edwards, D. J. (2019) · International journal of osteopathic medicine · doi:10.1016/j.ijosm.2019.11.003 · Cited by 4
Die gelernte Placeboantwort im Immunsystem
Hörbelt, T., Hetze, S., Schedlowski, M., & Lückemann, L. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00945-6 · Cited by 3
Self-citationDer Schein trügt nicht – klinische Evidenz und neue Forschungsansätze zum Open-label-Placebo
Nestoriuc, Y., & Kleine‐Borgmann, J. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00953-6 · Cited by 3
Colagiuri, B., Sharpe, L., Ambarchi, Z., Glozier, N., Bartlett, D. J., Costa, D. S. J., & Scott, A. J. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044045 · Cited by 3
Liu, T. (2021) · Clinical Psychological Science · doi:10.1177/21677026211009799 · Cited by 3
“Placebo effects are now known to be clinically relevant (Bingel et al., 2011; Kam-Hansen et al., 2014; Rief et al., 2011) and thus can be potentially taken advantage of to improve treatment outcomes and patient benefit (Colloca & Barsky, 2020; Enck et al., 2013; Evers et al., 2018).”
BackgroundJockenhöfer, F., Knust, C., Benson, S., Schedlowski, M., & Dissemond, J. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13996_g · Cited by 3
Self-citationPlacebo effects: the need for a new perspective and conceptualization
Benedetti, F., Frisaldi, E., & Shaibani, A. I. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1475228 · Cited by 4
A Matter of Perspective: Sham Surgery as Effective as Surgery, or Surgery as Uneffective as Sham?
Enck, P. (2018) · Pain Medicine · doi:10.1093/pm/pny127 · Cited by 3
Self-citationLi, Q., Detke, M. J., Paul, S. M., Potter, W. Z., Zhang, F., Breier, A. F., Alphs, L. D., Wolkowitz, O. M., Ereshefsky, L., Grecco, G. G., et al. (2025) · medRxiv · doi:10.1101/2025.05.29.25328167 · Cited by 3
Influence of Placebo Analgesia in Pharmacological Treatment of Pain
Sanders, D., Colloca, L., & Finniss, D. G. (2020) · Future Drug Discovery · doi:10.4155/fdd-2019-0028 · Cited by 2
Ibancos‐Losada, M. D. R., Díaz‐Fernández, Á., Cortés‐Pérez, I., Obrero‐Gaitán, E., López-Moreno, V., & Osuna‐Pérez, M. C. (2024) · Biomedicines · doi:10.3390/biomedicines12061172 · Cited by 3
“Previous studies have shown that individual belief in the current experience critically influences response expectancy through learning mechanisms [31,32].”
BackgroundNeuroimaging as a Tool for Advancing Pediatric Psychopharmacology
Bartkoski, M., Tumberger, J., Martin, L. E., Choi, I., Lee, P., Strawn, J. R., Brooks, W. M., & Stancil, S. L. (2025) · Pediatric Drugs · doi:10.1007/s40272-025-00683-9 · Cited by 2
“Drug response is measured with structured questionnaires (e.g., patient self-report and clinician-assessed measures), which can contribute to variability in outcomes and challenges in accurately assessing treatment efficacy [11, 12].”
Open-label nondeceptive placebos
Kleine‐Borgmann, J., & Bingel, U. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-29884-4.00020-0 · Cited by 2
Self-citationOostwouder, C.-J., Vos, K., Schipholt, I. J. L., Merkus, M. R., Telders, T., van Deursen, D. F. A., Smit, M. D., van Eijk, M. D., Bontkes, H. J., Bouwman, F. H., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103681 · Cited by 2
“31,32 Additionally, the study design incorporated an extended pre-treatment observation period, allowing for the establishment of stable baseline symptom trajectories.”
RetractedAlnasralla, M. B., & Nasralla, B. H. (2026) · Cureus · doi:10.7759/cureus.100612 · Cited by 4
Hahn, S., Pauls, F., Wittenbecher, H., Maehder, K., Löwe, B., Blankenburg, K., Toussaint, A. C., & Nestoriuc, Y. (2026) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2026.112546 · Cited by 3
A novel investigation of placebo analgesia through social communication in mice
Totsch, S. K., & Sorge, R. E. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114773 · Cited by 3
Placeboeffekte in der Schmerztherapie
Klinger, R., Schwartz, M., & Bingel, U. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00942-9 · Cited by 3
Self-citationKrefting, F., Hölsken, S., Benson, S., Schedlowski, M., & Sondermann, W. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19258 · Cited by 3
Self-citationA qualitative study of imaginary pills and open-label placebos in test anxiety
Buergler, S., Sezer, D., Busch, A., Enzmann, M., Bakis, B., Locher, C., Bagge, N., Kirsch, I., Carvalho, C., & Gaab, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291004 · Cited by 3
“The clinical potential of placebos and specifically OLPs is evident and further research on their beneficial effect is being called for [9, 10].”
Clemmesen, M. E. R., Jørgensen, A. R., Nielsen, V. W., Holgersen, N. K., Nissen, C., Thyssen, J. P., Egeberg, A., & Thomsen, S. F. (2023) · JEADV Clinical Practice · doi:10.1002/jvc2.218 · Cited by 2
Chuang, L.-C., Panitz, C., & Mueller, E. M. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100705 · Cited by 2
Italian adaptation of the Multidimensional Iowa Suggestibility Scale (MISS)
Liuzza, M. T., Tolomeo, E., Occhiuto, G., Cilurzo, M., Martino, I., & Cerasa, A. (2024) · PeerJ · doi:10.7717/peerj.17145 · Cited by 2
“It would allow for improving strategies to control placebo responses minimizing their effect in randomized clinical trials, helping in the interpretation of study results, and maximizing it to improve treatment benefits ( Enck et al., 2013 ).”
MethodÇakır, F., Gerçek, H., Ozturk, S., Çolak, T. K., Sarı, Z., & Polat, M. G. (2024) · Evaluation & the Health Professions · doi:10.1177/01632787241268211 · Cited by 3
“Expectations for a physiotherapy programme, as non-speci fi c treatment components, can cause subjective psychological changes and have mechanisms that can direct placebo-like effects (Enck et al., 2013).”
Perispinal etanercept stroke trial design: PESTO and beyond
Tobinick, E. L., Ucci, D., Bermudo, K., & Asseraf, S. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2390636 · Cited by 2
“…Heightened expectations of a favorable outcome due to widespread favorable media coverage in Australia and New Zealand, the sites of the RCT [136,137]; (3) PESTO’s [inadvertent] use of a painful acidic solution as its placebo control (Sterile saline solution (0.9% sodium chloride solution for…”
InfluentialPain, mindfulness, and placebo: a systematic review
Lopes, A., Sampaio, R., & Tavares, I. (2024) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2024.1432270 · Cited by 3
“The potential to harness the placebo effect (Scott et al., 2008; Bingel et al., 2011) to influence therapy outcomes and benefit patients is currently being considered and discussed (Pollo and Benedetti, 2009; Enck et al., 2013).”
BackgroundRief, W., & Κube, T. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01784-5 · Cited by 3
Self-citationSchlögelhofer, M., Lin, A. P., Markulev, C., Schäfer, M. R., McGorry, P. D., Nelson, B., Street, R., Mossaheb, N., Smesny, S., Hickie, I. B., et al. (2025) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674251361758 · Cited by 2
“Third, since non-adherence was not a primary focus of the study, we did not assess many factors that are potentially relevant for non-adherence behaviors (Enck et al., 2013; Kane et al., 2013).”
Injection-Based Therapies for the Management of Hip and Knee Osteoarthritis
Seah, M. K. T., Neufeld, M. E., Howard, L. C., Garbuz, D. S., & Masri, B. A. (2025) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.25.00239 · Cited by 4
Zimmermann‐Viehoff, F., Steckhan, N., Meißner, K., Deter, H., & Kirschbaum, C. (2015) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587215588642 · Cited by 3
“Classical conditioning and expectation are considered to be the most prominent mechanisms of the placebo effect.(2) Besides, data from placebo analgesia studies suggest that a reduction of stress and anxiety plays a crucial role for the placebo analgesic response(1,3-6) and may also be relevant for placebo effects in…”
BackgroundWeimer, K., & Enck, P. (2014) · Clinical Investigation · doi:10.4155/cli.14.78 · Cited by 2
Self-citationAre all placebo respondents non-smokers?
Enck, P., Weimer, K., & Klosterhalfen, S. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.06.012 · Cited by 2
“Recent reports on the placebo response (PR) rates in randomized controlled trials (RCT) across a variety of diseases and clinical conditions indicate that it can range up to 50% or higher, depending (among others) on the type of primary endpoint chosen (with patient-reported outcome (PRO) resulting in higher PR than b…”
BackgroundSelf-citationRosén, A., Lekander, M., Jensen, K. B., Sachs, L., Petrović, P., Ingvar, M., & Enblom, A. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/3925878 · Cited by 7
“Expectancy is accepted as one of the key contributors of the placebo effect [2] and a wide range of studies of placebo treatments have elucidated pathways through which placebos can be activated, often described as an interaction between psychological processes (e.”
BackgroundRetracted
Metadata
- Authors
- Enck, P., Bingel, U., Schedlowski, M., & Rief, W.
- Affiliations
- Universitätsklinikum Tübingen (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Essen University Hospital (DE)
- Philipps University of Marburg (DE)
- Corresponding author
- Enck, Paul
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-03
- Volume
- 12
- Issue
- 3
- Pages
- 191-204
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2062838995
- Cited by
- 671
- References
- 168
- Citations by year
- 2026: 32 · 2025: 53 · 2024: 45 · 2023: 50 · 2022: 41 · 2021: 51 · 2020: 58 · 2019: 53 · 2018: 63 · 2017: 54 · 2016: 51 · 2015: 47 · 2014: 50 · 2013: 23
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- placebo response, placebo effect, drug development, clinical trials, patient expectations, learning mechanisms, personalized medicine, genetic susceptibility, drug efficacy
- MeSH terms
- Clinical Trials as Topic, Humans, Physician-Patient Relations, Drug Design, Placebo Effect, Treatment Outcome, Drug Discovery, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.